SCHEMBL23086296

SCHEMBL23086296

CCCCCCCCCCCCCCCCCC(=O)N1CCN(C(=O)CCC(=O)O)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 4/20 0.67
GNAI1 P63096 4/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
TDP1 Q9NUW8 3/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
GNAO1 P09471 3/20 0.58
GPR84 Q9NQS5 7/20 0.57
PPARG P37231 7/20 0.57
PPARD Q03181 7/20 0.57
PPARA Q07869 7/20 0.57
HDAC11 Q96DB2 5/20 0.57
TSHR P16473 4/20 0.57
PTPN1 P18031 3/20 0.57
ALDH1A1 P00352 2/20 0.57
TLR2 O60603 2/20 0.57
FABP4 P15090 2/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
ESR1 P03372 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044731 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL8972813 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL1045855 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL8972980 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL8972823 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL8972566 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL4450061 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL7060548 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL768398 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1
SCHEMBL9415758 0.90 L3MBTL1 (0.80) GNAI3GNAI1L3MBTL1TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600744-B2 Method for producing oligonucleic acid compound NIPPON SHINYAKU CO., LTD. (JP) 2026-04-14 US disclosed
US-12600743-B2 Method for producing oligonucleic acid compound NIPPON SHINYAKU CO., LTD. (JP) 2026-04-14 US disclosed
US-20240254158-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND NIPPON SHINYAKU CO., LTD. (JP) 2024-08-01 US disclosed
EP-4332111-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND Nippon Shinyaku Co., Ltd. (JP) 2024-03-06 EP disclosed
US-11560401-B2 Method for preparing oligonucleic acid compound NIPPON SHINYAKU CO., LTD. (JP) 2023-01-24 US disclosed
US-20230014840-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND NIPPON SHINYAKU CO., LTD. (JP) 2023-01-19 US disclosed
US-20230018780-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND NIPPON SHINYAKU CO., LTD. (JP) 2023-01-19 US disclosed
WO-2022230954-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND 日本新薬株式会社 2022-11-03 WO disclosed
EP-4059943-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND Nippon Shinyaku Co., Ltd. (JP) 2022-09-21 EP disclosed
EP-4059944-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND Nippon Shinyaku Co., Ltd. (JP) 2022-09-21 EP disclosed
CN-114981280-A Method for producing oligonucleotide compound 日本新药株式会社 2022-08-30 CN disclosed
CN-114981281-A Method for producing oligonucleotide compound 日本新药株式会社 2022-08-30 CN disclosed
EP-3792269-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND Nippon Shinyaku Co., Ltd. (JP) 2021-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600743-B2 Method for producing oligonucleic acid compound SUB1, CTDSP1, POLR1A GNAI3 3218/4885GNAI1 1767/4885L3MBTL1 1074/4885
US-20230018780-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND POLRMT, POLR2H, POLM GNAI3 2775/4885GNAI1 2148/4885L3MBTL1 3702/4885
US-11560401-B2 Method for preparing oligonucleic acid compound POLRMT, POLI, POLR2H GNAI3 2933/4885GNAI1 2564/4885L3MBTL1 2732/4885
US-20240254158-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND POLRMT, CYC1, MRM1 GNAI3 4104/4885GNAI1 2769/4885L3MBTL1 1268/4885
US-20230014840-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND DNASE1, XRN2, FBL GNAI3 1696/4885GNAI1 445/4885L3MBTL1 697/4885
US-12600744-B2 Method for producing oligonucleic acid compound NSUN2, SUB1, RPA1 GNAI3 2068/4885GNAI1 562/4885L3MBTL1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.